PATH, PO Box 900922, Seattle, WA 98121, USA.
Vaccine. 2013 Oct 1;31(42):4759-64. doi: 10.1016/j.vaccine.2013.08.010. Epub 2013 Aug 17.
Vaccination is considered the most cost-effective approach to preventing infectious diseases, yet better formulations and delivery methods for efficient distribution and administration of vaccines are needed, especially for low-resource settings. A fast-dissolving tablet (FDT) that could be packaged in a compact stackable blister sheet is a potentially attractive option for formulating oral vaccines, since it would minimally impact the cold chain and could potentially be administered directly to patients without reconstitution. This study focused on using one component of a live attenuated trivalent vaccine under development to produce a FDT for the prevention of diarrhea induced by enterotoxigenic Escherichia coli (ETEC). Ten formulations were prepared and freeze dried to produce FDTs. Three freezing conditions were explored, along with different drying and package sealing methods. Physical properties examined included structural integrity, dissolution time, moisture content, and glass transition temperature. Bacterial viability was tested by assaying for colony-forming units. The formulation compositions and freeze-drying parameters were adjusted in an iterative process to arrive at a promising formulation for the ETEC vaccine tablet. This formulation included sucrose and trehalose as cryoprotectants; phosphate and glutamate salts as buffers and stabilizers; and Natrosol(®), polyvinylpyrrolidone, and mannitol as binders. The process loss in viability during freeze drying was less than 0.3 log 10 (50% recovery) for the optimized vaccine tablet formulation. The final tablets were robust, disintegrated in less than 10s, and preserved the bacteria at 2-8°C for at least 12 months with less than 0.4 log 10 loss (40% recovery) in viability during storage. This study indicates that the FDT produced by freeze drying directly in a blister sheet could be a practical option for formulating ETEC vaccines for oral immunization and help to facilitate delivery of lifesaving vaccines, particularly in low-resource settings.
疫苗接种被认为是预防传染病最具成本效益的方法,但需要更好的配方和更有效的疫苗分发和管理方法,特别是在资源匮乏的环境下。一种可快速溶解的片剂(FDT)可以装在一个紧凑的可堆叠的泡罩片中,对于开发口服疫苗来说是一个很有吸引力的选择,因为它对冷链的影响最小,并且可以无需复水直接施用于患者。本研究专注于使用一种正在开发的减毒活三价疫苗的一个成分来生产一种用于预防肠产毒性大肠杆菌(ETEC)引起的腹泻的 FDT。制备了十种配方并进行冷冻干燥以生产 FDT。探索了三种冷冻条件,并结合不同的干燥和包装密封方法。检查了物理性能包括结构完整性、溶解时间、水分含量和玻璃化转变温度。通过测定集落形成单位来测试细菌活力。通过迭代调整配方组成和冷冻干燥参数,得到了一种有前途的 ETEC 疫苗片剂配方。该配方包括蔗糖和海藻糖作为冷冻保护剂;磷酸盐和谷氨酸盐作为缓冲剂和稳定剂;以及 Natrosol®、聚乙烯吡咯烷酮和甘露醇作为粘合剂。在冷冻干燥过程中,优化后的疫苗片剂配方的活菌损失小于 0.3log10(50%回收)。最终的片剂坚固,崩解时间不到 10 秒,在 2-8°C 下储存至少 12 个月,活菌损失小于 0.4log10(40%回收)。本研究表明,直接在泡罩片中冷冻干燥生产的 FDT 可能是一种实用的 ETEC 疫苗口服免疫配方选择,并有助于在资源匮乏的环境中更有效地提供救命疫苗。